Dashboard
Manage Tickers

VALNValneva SE

Nasdaq valneva.com


$ 7.13 $ -0.17 (-2.37 %)    

Tuesday, 10-Sep-2024 15:19:21 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 468.28 $ 9.96 (2.17 %)
DIA $ 409.73 $ 1.01 (0.25 %)
SPY $ 554.79 $ 5.63 (1.03 %)
TLT $ 100.61 $ -0.08 (-0.08 %)
GLD $ 232.25 $ -0.37 (-0.16 %)
$ 7
$ 7.23 x 100
-- x --
-- - --
$ 6.39 - $ 14.94
15,754
na
-5
$ 2.13
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

pfizer-and-valneva-partnered-lyme-disease-vaccine-shows-effectiveness-as-booster-shot-in-mid-stage-study
Pfizer And Valneva Partnered Lyme Disease ...
09/03/2024 18:37:07

Valneva and Pfizer released data from their Phase 2 study of the Lyme disease vaccine candidate VLA15, showing strong immune re...

the-analyst-landscape-6-takes-on-valneva
The Analyst Landscape: 6 Takes On Valneva
09/03/2024 15:00:49

hc-wainwright--co-reiterates-buy-on-valneva-maintains-26-price-target
HC Wainwright & Co. Reiterates Buy on Valn...
09/03/2024 14:51:30

HC Wainwright & Co. analyst Edward White reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $26 price target.

Core News & Articles
Valneva And Pfizer Announced Further Immun...
09/03/2024 09:39:04

The immune response and safety profile of VLA15 one month after receiving the second booster dose were similar to those reporte...

why-nikola-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Nikola Shares Are Trading Lower By Aro...
08/19/2024 17:37:46

zim-integrated-shipping-services-posts-upbeat-earnings-joins-fubotv-foghorn-therapeutics-and-other-big-stocks-moving-higher-on-monday
ZIM Integrated Shipping Services Posts Upb...
08/19/2024 14:25:31

analyst-scoreboard-8-ratings-for-valneva
Analyst Scoreboard: 8 Ratings For Valneva
08/14/2024 19:00:37

hc-wainwright--co-reiterates-buy-on-valneva-maintains-26-price-target
HC Wainwright & Co. Reiterates Buy on Valn...
08/14/2024 18:40:57

HC Wainwright & Co. analyst Edward White reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $26 price target.

valneva-reaffirmed-its-2024-guidance-expects-total-revenues-of-170m-190m-and-rd-investments-between-60m-75m
Valneva Reaffirmed Its 2024 Guidance: Expe...
08/13/2024 05:31:45

Full-year 2024 Financial Guidance Confirmed Expected total revenues between €170 million and €190 million, including €160 mi...

valneva-h1-revenue-708m-down-from-737m-yoy-net-profit-34m-up-from-net-loss-35m-yoy
Valneva H1 Revenue €70.8M Down From €73.7M...
08/13/2024 05:30:53

hc-wainwright--co-reiterates-buy-on-valneva-maintains-26-price-target
HC Wainwright & Co. Reiterates Buy on Valn...
08/02/2024 10:18:32

HC Wainwright & Co. analyst Edward White reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $26 price target.

valneva-and-limmatech-forge-strategic-partnership-to-fast-track-development-of-leading-tetravalent-shigella-vaccine
Valneva And LimmaTech Forge Strategic Part...
08/01/2024 05:58:18

Valneva obtains exclusive worldwide license for LimmaTech's S4V Shigella vaccine candidate and adds an attractive Phase 2...

what-analysts-are-saying-about-valneva-stock
What Analysts Are Saying About Valneva Stock
07/22/2024 21:00:34

hc-wainwright--co-reiterates-buy-on-valneva-maintains-26-price-target
HC Wainwright & Co. Reiterates Buy on Valn...
07/22/2024 18:33:44

HC Wainwright & Co. analyst Edward White reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $26 price target.

cepi-and-eu-grant-valneva-413m-to-enhance-global-reach-of-chikungunya-vaccine-ixchiq
CEPI And EU Grant Valneva $41.3M To Enhanc...
07/22/2024 06:02:07

Valneva to receive up to $41.3 million from CEPI and the European Union to expand access to chikungunya vaccine, IXCHIQ® Fun...

pfizervalnevas-vaccine-study-for-tick-borne-infection-completes-primary-vaccination-series-plans-approval-in-2026
Pfizer/Valneva's Vaccine Study For Tick-Bo...
07/18/2024 18:05:07

Pfizer and Valneva announced the completion of the primary vaccination series in the Phase 3 VALOR trial for their Lyme disease...

Core News & Articles
Pfizer And Valneva Announce Primary Vaccin...
07/17/2024 20:02:27

Participants completed primary vaccination series (3 doses) with VLA15 Primary vaccination series to be followed by a booster a...

the-european-commission-has-granted-marketing-authorization-in-europe-for-valnevas-single-dose-vaccine-ixchiq-for-individuals-18-years-of-age-and-older-the-company-expects-to-deliver-the-first-doses-in-europe-in-q4-of-2024
The European Commission Has Granted Market...
07/01/2024 10:40:29

hc-wainwright--co-reiterates-buy-on-valneva-maintains-26-price-target
HC Wainwright & Co. Reiterates Buy on Valn...
06/28/2024 15:19:44

HC Wainwright & Co. analyst Edward White reiterates Valneva (NASDAQ:VALN) with a Buy and maintains $26 price target.

the-analyst-landscape-6-takes-on-valneva
The Analyst Landscape: 6 Takes On Valneva
06/24/2024 20:00:52

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION